CSI Market
Sign In | Register

Kythera Biopharmaceuticals Inc (KYTH) Annual Cash Flow Statement

Annual · GAAP · USD millions
Access KYTH quarterly Cash Flow →
The data below summarizes Kythera Biopharmaceuticals Inc's cash flow activity from to Dec 31 2014, enabling a period-by-period view of cash movement.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2014)
12 Months 		(Dec 31 2013) (Dec 31 2010) (Dec 31 2013)
Operating Activities
Income-135.62
Depreciation & amortization0.30
Amortization of Other Assets1.96
Increase (Decrease) in Deferred Revenue0.00
Restructuring & Impairment Charges0.00
Provision For Loan Losses Expensed0.00
Increase (Decrease) in Inventories0.00
R & D, Environmental and Other Expense0.00
Gain (Loss) on Disposition of Assets0.00
Share-based Compensation12.45
Income (Loss) from Equity Method Investments0.00
Increase (Decrease) in Restricted Cash for Operating Activities5.06
Amortization Of Preferred Stock Warrant Value-
Revaluation Of Convertible Preferred Stock Warrants-
Increase Decrease In Sublicense Payment-
Increase Decrease In Deferred Development Funds-2.15
Investment Income Amortization Of Premium-
Research And Development Asset Acquired Other Than Through Business Combination Written Off53.03
Income taxes0.00
Losses/ -gains on Investments net0.00
Accounts Receivable0.00
Increase (Decrease) in Accounts Payable and Accrued Liabilities4.60
Accrued Expense0.00
Deferred Revenue and Customer Advances and Deposits0.00
Increase (Decrease) in Prepaid Expense and Other Assets-0.11
Other Working Capital0.94
Other Noncash Income (Expense)0.00
Other net0.00
Payments for (Proceeds from) Other Operating Activities0.00
Discontinued operations0.00
Net Cash flow from Operating Activities-59.53
Investing Activities
Capital Expenditures-2.06
Sale of Capital Items0.00
Proceeds from Sale and Maturity of Marketable Securities2.03
Payments to Acquire Marketable Securities-63.51
Real Estate Investments0.00
Proceeds From Maturity Of Marketable Securities45.24
Restricted Cash and Investments Increase (Decrease)0.00
Payments for (Proceeds from) Loans0.00
Payments for (Proceeds from) Deposits0.00
Payments for (Proceeds from) Other Investments0.00
Payments for (Proceeds from) Federal Reserve and FHLB0.00
Acquisition Net of Cash Acquired0.00
Interest in Subsidiaries and Affiliates0.00
Sale of businesses0.00
Accounts payable0.00
Receivables0.00
Payments for (Proceeds from) Other Investing Activities0.00
Other Net0.00
Discontinued operations0.00
Net Cash Flow from Investing Activities-18.30
Financing Activities
Short-term debt Net0.00
Other borrowing transactions0.00
Long-term debt - borrowings-5.87
Long-term debt - repayments0.00
Federal Home Loan Bank and Federal Funds0.00
Issuances / -repurchases of Comm. Stock0.00
Partnership and Parent Transactions0.00
Issuances / -repurchases of Pref. Stock0.00
Deposits, Annuities, Contract Holders Funds0.00
Other financing activities net0.00
Other net0.00
Proceeds From Stock Options And Warrants Exercised1.40
Payments of Dividends, Preferred Stock and Preference Stock0.00
Dividends paid0.00
Net Cash Flow from Financing Activities-4.47
Effect of exchange rate on cash flow0.00
Discontinued operations0.00
Free Cash Flow-61.59
Total Cash Flow-82.29
4 historic quarters locked

Sign in to unlock the full Kythera Biopharmaceuticals Inc cash flow history.

Sign In Create Free Account

About KYTH Annual Cash Flow Statement

What this statement shows

This page presents issuer-reported cash flow data, including operating, investing, financing, net, and free cash flow, as disclosed in SEC 10-K filings and normalized by CSIMarket.

Source & verification

  • Form: 10-K
  • Filed with the SEC: n/a

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - normalization in the CSIMarket.com database.

Figures are derived from filed reports and may be restated. Historical data is subject to revision.

Untitled Document 





                    


    



  Get the full CSIMarket dataset:
  Subscribe
  API
  License